SELLAS Life Sciences Group, Inc.
SLS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001390478
No open-market purchases or sales by SELLAS Life Sciences Group, Inc. insiders were filed in the last 90 days; 193 institutions reported holding it in 13F filings for Q2 2026, worth $1.08B in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding SELLAS Life Sciences Group, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 45 | 79 | +34 |
| Shares | 14.3M | 26.8M | +12.5M (+87.2%) |
| Value | $15.5M | $58.7M | +$43.2M (+279.6%) |
New holders (40)
Institutions that held SELLAS Life Sciences Group, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
Sold out (6)
Institutions that held SELLAS Life Sciences Group, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Virtu Financial LLC | 53,861 | $58.0K |
| Renaissance Technologies LLC | 34,892 | $37.7K |
| Jain Global LLC | 27,400 | $29.6K |
| Hudson Bay Capital Management LP | 20,660 | $22.3K |
| Two Sigma Securities, LLC | 12,969 | $14.0K |
| Schonfeld Strategic Advisors LLC | 12,481 | $13.5K |